InvestorsHub Logo

DewDiligence

10/21/16 8:19 AM

#13487 RE: biotech_researcher #13486

GE is a pretty good proxy for global trade. Its tepid guidance for organic growth is consistent with the observation in #msg-125829175.

biotech_researcher

10/21/16 9:11 AM

#13488 RE: biotech_researcher #13486

Honeywell was disappointing as well. I'm surprised the DOW is not down 300 points this morning on this GE Honeywell news. Neither party is talking about any fiscal stimulus, so the markets are way overvalued, except tech, cloud, storage.

DewDiligence

10/22/16 12:14 PM

#13494 RE: biotech_researcher #13486

GE’s oil-stained results:

http://www.wsj.com/articles/ge-profit-falls-as-revenue-growth-less-than-expected-1477047596

The big problem for sales and earnings continues to be oil. Low prices have triggered the postponement or cancellation of major projects in the industry, hurting companies like GE that sell equipment for pumping and drilling.

Oil-and-gas revenue fell 25% in the third quarter, and segment profit fell 42%. GE has already been cutting costs aggressively in the oil and gas unit, closing facilities and trying to standardize product offerings to reduce expenses. Chief Financial Officer Jeffrey Bornstein said the oil and gas business was on pace to hit a cost-cutting target of roughly $800 million for the year, with room for more “incremental” cost reduction in the coming year.